XML 42 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 16. Segment Reporting
9 Months Ended
Sep. 30, 2016
Notes  
Note 16. Segment Reporting

Note 16.          Segment Reporting

 

The Company has renamed its “Fully Insured” segment “Specialty Health”.  Specialty Health more accurately reflects the niche nature of the products that IHC markets in this segment and continues to expand into since its exit from the major medical market.

 

The Insurance Group principally engages in the life and health insurance business. Information by business segment is presented below for the periods indicated (in thousands):

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2016

 

2015

 

2016

 

2015

Revenues:

 

 

 

 

 

 

 

 

Medical Stop-Loss (A)

$

       5,433 

$

      53,320 

$

     21,397 

$

    160,310 

Specialty Health

 

     44,684 

 

      45,193 

 

   126,454 

 

    141,356 

Group disability, life and DBL

 

     26,196 

 

      24,404 

 

     77,409 

 

       65,879 

Individual life, annuities and other (A)

 

           717 

 

        7,987 

 

        2,053 

 

       25,287 

Corporate

 

           620 

 

              45 

 

        2,350 

 

            137 

 

 

     77,650 

 

    130,949 

 

   229,663 

 

    392,969 

Gain on sale of subsidiary to joint venture

 

                - 

 

      10,161 

 

                 - 

 

       10,161 

Net realized investment gains (losses)

 

       2,367 

 

       (1,109)

 

        3,945 

 

         2,991 

Net impairment losses recognized in earnings

 

      (1,475)

 

          (228)

 

      (1,475)

 

           (228)

    Total revenues

$

     78,542 

$

    139,773 

$

   232,133 

$

    405,893 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

 

 

 

 

 

 

 

   before income taxes:

 

 

 

 

 

 

 

 

Medical Stop-Loss (A)

$

       2,176 

$

        5,218 

$

     13,926 

$

      14,176 

Specialty Health (B)  

 

       1,369 

 

        2,399 

 

       3,754 

 

         5,231 

Group disability, life and DBL

 

       5,323 

 

        4,400 

 

     13,533 

 

      10,774 

Individual life, annuities and other (A)(C)  

 

         (410)

 

        3,623 

 

     (1,888)

 

         1,238 

Corporate

 

      (1,908)

 

       (2,111)

 

     (7,106)

 

       (5,308)

 

 

       6,550 

 

      13,529 

 

     22,219 

 

      26,111 

Gain on sale of subsidiary to joint venture

 

                - 

 

      10,161 

 

                - 

 

        10,161

Net realized investment gains (losses)

 

       2,367 

 

       (1,109)

 

       3,945 

 

         2,991 

Net impairment losses recognized in earnings

 

      (1,475)

 

          (228)

 

     (1,475)

 

           (228)

Interest expense

 

         (440)

 

          (444)

 

     (1,366)

 

       (1,354)

    Income from continuing operations

 

 

 

 

 

 

 

 

       before income taxes

$

       7,002 

$

      21,909 

$

     23,323 

$

       37,681 

 

 

 

(A)                Substantially all of the business in the segment is coinsured. The current year’s activity primarily reflects income or expenses related to the coinsurance and the run-off of any remaining blocks that were not coinsured.

 

(B)                 The Specialty Health segment includes amortization of intangible assets. Total amortization expense was $366,000 and $425,000 for the three months ended September 30, 2016 and 2015, respectively, and was $1,057,000 and $1,070,000, respectively, for the nine months ended September 30, 2016 and 2015. Amortization expense for the other segments is not material to their operating results.

 

(C)                The Individual life, annuities and other segment includes amortization of deferred charges in connection with the assumptions of certain ceded life and annuity policies amounting to $296,000 and $213,000 for the three months ended September 30, 2016 and 2015, respectively, and $1,949,000 and $629,000 for the nine months ended September 30, 2016 and 2015, respectively.